Mark Nedelman, MS, MBA

Chief Executive Officer

Mark Nedelman is a drug development and CRO veteran with more than 30 years experience.

He started his drug development career in the nuclear medicine research laboratory at Massachusetts General Hospital from 1983-87.  From there, he was recruited to start and head Preclinical Pharmacology at Centocor, where he was an Associate Director from 1987-1996 playing key roles in the development and approval of a number of first-in-class drugs.

In 1996, Mark joined the CRO industry where he held a number of leadership positions within Charles River Laboratories including being its Senior Director of Pharmacology, Surgery and Toxicology from 2000-2003 and then General Manager of a new, multi-site business unit, Interventional & Surgical Services.  Over the years, he has served as a drug development consultant to a number of biotechnology start-ups including Rockefeller University.

Mark holds a B.S. and M.S. in Biology from the University of Cincinnati and a M.B.A. from Northeastern University.